A Case of Severe Rebound after Switching from Fingolimod to Ocrelizumab

Autor:	Alevtina Ersoy, Mengucek Gazi Egitim ve Arastirma Hastanesi, Noroloji Klinigi, Erzincan, Turkiye, Canan Duman Ilki, Ceyda Tanoglu, Hasan Yaşar
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Internal medicine Cardiology Medicine Ocrelizumab General Medicine business Fingolimod medicine.drug
Zdroj:	Archives of Basic and Clinical Research. 3:43-46
ISSN:	2687-4482 2687-4520
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3def07be442c38de8be034cc9f2a70e2 https://doi.org/10.5152/abcr.2021.20031 Zobrazit plný text záznamu